FDA recall D-1251-2014

Shire Human Genetic Therapies, Inc. · Class I · drug

Product

VPRIV¿ (velaglucerase alfa for injection) , Lyophilized Powder, 400 Units/vial, Rx Only. Shire Human Genetic Therapies, Inc. 300 Shire Way, Lexington, MA 02421. NDC: 54092-701-04.

Reason for recall

Presence of Particulate Matter; Particulates identified as stainless steel and barium sulfate.

Distribution

US Nationwide including Puerto Rico; Mexico, Columbia

Key facts

Status
Terminated
Initiation date
2014-03-14
Report date
2014-04-30
Termination date
2016-08-31
Voluntary/Mandated
Voluntary: Firm initiated
Location
Lexington, MA, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1251-2014